Koninklijke Philips | PHG - Loan Capital


Koninklijke Philips reported EUR8.14B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Boston Scientific USD 11.01B 19M Dec/2025
Danaher USD 17.56B 855M Mar/2026
Demant DKK 18.98B 3.71B Dec/2025
Dexcom USD 1.3B 54.4M Mar/2026
Edwards Lifesciences USD 600M 1.7M Mar/2026
Fresenius EUR 9.22B 1.58B Dec/2025
General Electric Aerospace USD 18.17B 634M Mar/2026
Getinge SEK 8.92B 640M Dec/2025
Globus Medical USD 436K 9K Dec/2025
GN Store Nord DKK 8.1B 790M Mar/2026
Hitachi JPY 539.75B 1.11B Mar/2026
Idexx Laboratories USD 299.85M 74.99M Mar/2026
Insulet USD 929.5M 1.3M Mar/2026
Integra LifeSciences USD 1.83B 29.45M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.53B 1.91B Mar/2026
Koninklijke Philips EUR 8.14B 347.2M Dec/2025
Medtronic USD 27.88B 255M Dec/2025
Philips EUR 6.89B 43M Mar/2026
ResMed USD 404.17M 245K Mar/2026
Smith & Nephew USD 3.3B 22M Dec/2025
Steris USD 1.81B 85.6M Mar/2026
Stryker USD 14.22B 635M Mar/2026
Teleflex USD 2.51B 27.18M Mar/2026
Terumo JPY 99.91B 13M Mar/2026
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026